India's Pharmaceutical Exports

Country Profile

Nigeria

Nigeria is a major destination for Indian pharmaceutical exports — $727M in FY 2025–26, with 2.1× growth over the past decade. Medicines accounts for 66% of shipments, with vaccines contributing $169M. The compound annual growth rate since FY2015 stands at 6.8%.

🇳🇬 #7 Destination · $727M · 2.1× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$727M
Exports FY2025–26 DGCIS
2.1×
Growth FY2015→2026
2.3%
Share of India Total
#7
Rank Among 178 Markets
6.8%
CAGR FY2015→2026
Nigeria is a major destination for Indian pharmaceutical exports — $727M in FY 2025–26, with 2.1× growth over the past decade. Medicines accounts for 66% of shipments, with vaccines contributing $169M. The compound annual growth rate since FY2015 stands at 6.8%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $482M (66.2%) Vaccines $169M (23.2%) Medicine Ingredients $64.4M (8.9%) Surgical & Hospital Supplies $6.40M (0.9%) Traditional & Herbal $5.93M (0.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Nigeria in the RBI overseas direct investment dataset (2011–2026).